T-cell homing to the pancreas in autoimmune mouse models of diabetes: In vivo MR imaging

Radiology

Volumn 236, Issue 2, 2005, Pages 579-587

  Billotey, Claire ^a   Aspord, Caroline ^a   Beuf, Olivier ^a   Piaggio, Eliane ^a   Gazeau, Florence ^a   Janier, Marc F ^a   Thivolet, Charles ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL LABELING; CELL SURVIVAL; CONTROLLED STUDY; DIABETES MELLITUS; FOLLOW UP; HISTOGRAM; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; PANCREAS ISLET; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; AUTOIMMUNE DISEASES; DIABETES MELLITUS, EXPERIMENTAL; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED NOD; PANCREAS; RECEPTORS, LYMPHOCYTE HOMING;

EID: 22544486832     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2362040603     Document Type: Article

References (37)

1. Hardy J, Edinger M, Bachmann MH, Negrin RS, Fathman CG, Contag CH. Bioluminescence imaging of lymphocyte trafficking in vivo. Exp Hematol 2001; 29:1353-1360.
2. Korf J, Veenma-van der Duin L, Brinkman-Medema R, Niemarkt A, de Leij LF. Divalent cobalt as a label to study lymphocyte distribution using PET and SPECT. J Nucl Med 1998; 39:836-841.
3. Weissleder R, Cheng HC, Bogdanova A, Bogdanov A Jr. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 1997; 7:258-263.
4. Schulze E, Ferrucci JT Jr, Poss K, Lapointe L, Bogdanova A, Weissleder R. Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro. Invest Radiol 1995; 30:604-610.
5. Dodd SJ, Williams M, Suhan JP, Williams DS, Koretsky AP, Ho C. Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J 1999; 76:103-109.
6. Bulte JW, Zhang S, van Gelderen, P et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A 1999; 96:15256-15261.
7. Bulte JW, Douglas T, Witwer B, et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 2001; 19:1141-1147.
8. Hill JM, Dick AJ, Raman VK, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003; 108:1009-1014.
9. Kraitchman DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003; 107:2290-2293.
10. Moore A, Sun PZ, Gory D, Hogemann D, Weissleder R, Lipes MA. MRI of insulitis in autoimmune diabetes. Magn Reson Med 2002; 47:751-758.
11. Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 2003; 24:1001-1011.
12. Billotey C, Wilhelm C, Devaud M, Bacri JC, Bittoun J, Gazeau F. Cell internalization of anionic maghemite nanoparticles: quantitative effect on magnetic resonance imaging. Magn Reson Med 2003; 49:646-654.
13. Eisenbarth GS. Type 1 diabetes mellitus: a chronic autoimmune disease. N Engl J Med 1986; 314:1360-1368.
14. Castano L, Eisenbarth GS. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 1990; 8:647-679.
15. Thivolet C, Bendelac A, Bedossa P, Bach JF, Carnaud C. CD8+ T cell homing to the pancreas in the nonobese diabetic mouse is CD4+ T cell-dependent. J Immunol 1991; 146:85-88.
16. Vizier C, Bercovici N, Heurtier A, et al. Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts. J Immunol 2000; 165:6314-6321.
17. Fauconnier N, Pons JN, Roger J, Bee A. Thiolation of maghemite nanoparticles by dimercaptosuccinic acid. J Colloid Interface Sci 1997; 194:427-433.
18. Fabien N, Bergerot I, Maguer-Satta V, Orgiazzi J, Thivolet C. Pancreatic lymph nodes are early targets of T cells during adoptive transfer of diabetes in NOD mice. J Autoimmun 1995; 8:323-334.
19. Hoglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 1999; 189:331-339.
20. Wilhelm C, Gazeau F, Bacri JC. Magnetophoresis and ferromagnetic resonance of magnetically labeled cells. Eur Biophys J 2002; 31:118-125.
21. Weissleder R, Moore A, Mahmood U, et al. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000; 6:351-355.
22. Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002; 23:1553-1561.
23. Josephson L, Tung CH, Moore A, Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 1999; 10:186-191.
24. Bhorade R, Weissleder R, Nakakoshi T, Moore A, Tung CH. Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. Bioconjug Chem 2000; 11:301-305.
25. Lewin M, Carlesso N, Tung CH, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000; 18:410-414.
26. Delong R, Stephenson K, Loftus T, et al. Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery. J Pharm Sci 1997; 86:762-764.
27. Hoehn M, Kustermann E, Blunk J, et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 2002; 99:16267-16272.
28. Modo M, Cash D, Mellodew K, et al. Tracking transplanted stem cell migration using bifunctional contrast agent-enhanced, magnetic resonance imaging. NeuroImage 2002; 17:803-811.
29. Dodd CH, Hsu HC, Chu WJ, et al. Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide- derived superparamagnetic nanoparticles. J Immunol Methods 2001; 256:89-105.
30. Wu MX, Schlossman SF. Decreased ability of HIV-I tat protein-treated accessory cells to organize cellular clusters is associated with partial activation of T cells. Proc Natl Acad Sci U S A 1997; 94:13832-13837.
31. Bartz SR, Emerman M. Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8. J Virol 1999; 73:1956-1963.
32. Shen T, Weissleder R, Papisov M, Bogdanov A Jr, Brady TJ. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med 1993; 29:599-604.
33. Notkins AL, Lernmark A. Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 2001; 108:1247-1252.
34. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343:230-238.
35. Imagawa A, Hanafusa T, Tamura S, et al. Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity. Diabetes 2001; 50:1269-1273.
36. Signore A, Chianelli M, Ferretti E, et al. New approach for in vivo detection of insulitis in type I diabetes: activated lymphocyte targeting with 123I-labelled interleukin 2. Eur J Endocrinol 1994; 131:431-437.
37. Signore A, Picarelli A, Annovazzi A, et al. 123I-interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases. Nucl Med Commun 2003; 24:305-316.